AILERON THERAPEUTICS INC

FREE EMAIL WATCHDOG

Get free email notifications about news in AILERON THERAPEUTICS INC.

The service is free and you can unsubscribe at any time.

General | People (49) | Filings (68) | Investment rounds (4) | Stock | News

Industry: PHARMACEUTICAL PREPARATIONS [2834]

CIK Number: 0001420565

AILERON THERAPEUTICS INC is a publicly traded company

Trading symbol: ALRN

AILERON THERAPEUTICS INC is on the market more than 5 years.

News

2017-08-18

RPX Corporation (RPXC) is at $12.43 per share and Aileron Therapeutics, Inc ...
Stocks Gallery
In latest trading activity; RPX Corporation (RPXC) snatched the consideration from Investors, when its current damaging picture was seen that is promoting bad performance.

2017-08-10

Aileron Therapeutics Reports Second Quarter 2017 Financial Results
Nasdaq
10, 2017 (GLOBE NEWSWIRE) -- Aileron Therapeutics (NASDAQ:ALRN), the clinical-stage leader in the field of stapled peptide therapeutics for cancers and other diseases, today reported financial results for the second quarter ended June 30, 2017, and ...
Who Owns Aileron Therapeutics Inc (ALRN)? - Simply Wall St
Aileron Therapeutics, Inc. (ALRN) registers a price change of -3.08% while ... - Stocks Gallery

2017-08-08

Stock Buzz: Aileron Therapeutics, Inc. (ALRN) move to mark the closing value ...
NYSE Journal (press release)
Aileron Therapeutics, Inc. (ALRN) recognized an increased 0.16% move to mark the closing value at $12.16 on Monday. ALRN originated downfall move of -5.00% over prior week however the stock price shaped 12.59% so far this year - still in positive area.
Aileron Therap (ALRN) Receives Daily News Impact Score of 0.06 - Week Herald
Jefferies Group Comments on AILERON THERAP's Q2 2017 Earnings (NASDAQ:ALRN) - BNB Daily (blog)

2017-08-03

Aileron Therapeutics to Present at Canaccord Genuity 37th Annual Growth Conference
GlobeNewswire (press release)
Aileron is a clinical-stage biopharmaceutical company advancing stapled peptides, a novel class of therapeutics for cancers and other diseases. Stapled peptides are chemically stabilized alpha-helical peptides that are modified to improve their ...
Bank of America Corporation Begins Coverage on AILERON THERAP (NASDAQ:ALRN) - BNB Daily (blog)
AILERON THERAP (ALRN) Now Covered by Jefferies Group LLC - Week Herald

2017-07-30

Aileron Therapeutics Inc - Receive News & Ratings Daily
The Cerbat Gem
Aileron Therapeutics logo Aileron Therapeutics Inc (NASDAQ:ALRN) insider Lilly Ventures Fund I. Llc bought 250,000 shares of the firm's stock in a transaction dated Wednesday, July 5th.

2017-07-24

BofA/Merrill Lynch Starts Aileron Therapeutics Inc (ALRN) at Buy
StreetInsider.com
BofAMerrill Lynchh initiates coverage on Aileron Therapeutics Inc (NASDAQ: ALRN) with a Buy rating and a price target of $19.00.
Aileron Therap (ALRN) Coverage Initiated by Analysts at Jefferies Group LLC - Week Herald

2017-07-07

12 Biggest Mid-Day Gainers For Friday
Benzinga
Aileron Therapeutics Inc (NASDAQ: ALRN) shares climbed 7.3 percent to $14.27 after gaining 8.04 percent on Thursday. Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) rose 7.3 percent to $19.30.

AILERON THERAPEUTICS INC address

281 ALBANY STREET
CAMBRIDGE
02139

Company jurisdiction

DELAWARE

Entity type

Corporation

Earliest known filing

December 2007

Latest known filing

August 2017

Company filings

SEC filings are a great source of information for companies including investments, company events, and all sorts of other information.

AILERON THERAPEUTICS INC has 68 filings. View AILERON THERAPEUTICS INC filings.

Quarterly Reports

Investment Rounds

AILERON THERAPEUTICS INC recieved 4 investments.

People

We have found 49 people related to AILERON THERAPEUTICS INC.

Similar companies

Aileron Media, LLC, AILERON CAPITAL MANAGEMENT, LLC, AILERON CAPITAL FUND LTD, AILERON CAPITAL FUND L P